MarketInOut Stock Screener Log In | Sign Up
 

Ginkgo Bioworks Holdings Inc

NYSE • Healthcare • Biotechnology • Quote as of 10/23/2026
Ginkgo Bioworks Holdings Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization674.08 mln
Float49.11 mln
Earnings Date11/16/2026

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-3.19
Reliable

1-Year Forecast

8.00
Downside risk

Relative Strength

3 / 100
Severely lagging

Debt / Equity

0.96
Moderate leverage

Pre-Tax Margin

-264%
Severely loss-making

Business Description

Founded in 2008 and based in Boston, Ginkgo Bioworks helps companies across industries design and build living cells for practical use, from developing new drugs and agricultural solutions to improving food ingredients and industrial processes. Its platform combines automation, artificial intelligence, and genomic tools to make cell engineering faster and more accessible for research and commercial applications. The company also operates a biosecurity division that monitors environmental and biological threats through sensor networks and data analytics.

Key Fundamentals

EPS-5.14
ROE-61.95
RPS2.26
ROIC-41.17
ROA-28.34
EBITDA, mln-243
EV / EBITDA-3.93
EV / EBIT-3.23
Revenue, mln112
EV / Revenue8.53

Quote Details

Last 9.99
Change 0.28 (2.88%)
Open 9.61
Volume 1,149,745
Turnover 11,485,952
Average Volume 3,589,019

Financial Ratios

Pre-Tax Profit Margin-264
Leverage Ratio2.36
Current Ratio4.57
Price / Book1.89
Price / Tangible Book2.11
Debt / Equity0.96
Price / Sales6.70

Financial Strength

Altman Z-Score-8.63
Piotroski F-Score 1 / 9
Beneish M-Score-3.19
1-Year Target Price8.00
Short Ratio3.90
Short % of Float13.64

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.73% 16 / 100   
1 Month -2.54% 33 / 100   
2 Months 32.32% 97 / 100   
6 Months 26.94% 93 / 100   
1 Year -21.83% 12 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog